What motivates SARS-CoV-2 vaccine trial participants? A pre- and post-participation survey study.

ABSTRACT:

Background

Scientific advancement, including the testing and licensing of new drugs, relies heavily on clinical trials with healthy individuals. The motivations of clinical trial participants have been discussed intensively, as some worry that financial compensation may distract from the intrinsic risk of clinical research. Herein, we investigated the motivations and decisional factors influencing SARS-CoV-2 clinical trial participants. Moreover, since most surveys are administered after clinical trial participation, we were interested in whether the results were tainted by recall bias.

Methods

This was a cross-sectional observational study. Participants were administered a survey on two occasions, once before and once after participation in a clinical trial. The primary out

SUBMITTER: Lamers OAC 

PROVIDER: S-EPMC11539315 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature